Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
low recruiting
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Pusan National University Yangsan Hospital | OTHER |
This study aims for evaluating the effectiveness, safety and feasibility of additional acupuncture therapy for lung cancer patients who are under chemotherapy in an inpatient setting. The acupuncture therapy will be administered during a resting period between cycles of chemotherapy.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Acupuncture therapy | Experimental |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Acupuncture treatment | Procedure | Acupuncture treatment will be performed by licensed doctors in Korean Medicine using 0.20 mm (diameter) X 0.30 mm (length) sized disposable acupuncture on seven to ten consecutive days after admission to the Korean Medicine Hospital of Pusan National University. At least two sessions and a maximum of five sessions of acupuncture therapy will be administered per day. Acupuncture points consist of common points and additional points selected for typical complaints common in patients under chemotherapy. These points are as follows.
|
| Measure | Description | Time Frame |
|---|---|---|
| Change score of Functional Assessment of Cancer Therapy-Lung (FACT-L) scale from baseline | 7-10 days during a rest period between chemotherapy cycles |
| Measure | Description | Time Frame |
|---|---|---|
| Change score of Functional Assessment of Cancer Therapy-Lung (FACT-L) scale from baseline | 4-5 weeks from baseline (3-4 weeks after treatment termination) | |
| Change score of Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT fatigue) Scale from baseline |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Yun Seong Kim, PhD | Pusan National University Yangsan Hospital | Principal Investigator |
| Jun-Yong Choi, MS | Korean Medicine Hospital of Pusan National University | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Pusan National University Yangsan Hospital and Korean Medicine Hospital of Pusan National University | Yangsan | Gyeongsangnam-do | 626-770 | South Korea |
Not provided
| ID | Term |
|---|---|
| D008175 | Lung Neoplasms |
| ID | Term |
|---|---|
| D012142 | Respiratory Tract Neoplasms |
| D013899 | Thoracic Neoplasms |
| D009371 | Neoplasms by Site |
| D009369 | Neoplasms |
Not provided
Not provided
| ID | Term |
|---|---|
| D015670 | Acupuncture Therapy |
| ID | Term |
|---|---|
| D000529 | Complementary Therapies |
| D013812 | Therapeutics |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
|
| Baseline, 7-10 days after baseline, 4-5 weeks after baseline |
| Change of general condition assessment using visual analogue scale from baseline | Baseline, 7-10 days after baseline, 4-5 weeks after baseline |
| Adverse events | From study enrollment to the last follow-up (a maximum of day 36) |
| D008171 |
| Lung Diseases |
| D012140 | Respiratory Tract Diseases |